The results indicated that CFDTD treatment did not cause significant changes in FSH levels in PCOS compared with those noted in the control group (MD = −0.26, 95% CI (−0.77, 0.25), P=0.32) (Figure 6(a)). Here, BRD2 is linked to polycystic ovary syndrome.